Phase 2 Clinical Trial to Optimize Immune Coverage of SARS-CoV-2 Existing and Emerging Variants (short title, COVID-19 Adaptive Variant Immunologic Landscape Trial (COVAIL Trial)

Project: Research project

Project Details

Description

Conducting procedures to isolate and cryopreserve Peripheral Blood Mononuclear Cells (PBMC) for this study
StatusFinished
Effective start/end date3/31/22 → 8/31/24

Funding

  • Leidos Biomedical Research, Inc.: $18,000.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint